TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
898
Employees898
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
898
Employees898

TMDX Key Statistics

Market cap
2.38B
Market cap2.38B
Price-Earnings ratio
15.80
Price-Earnings ratio15.80
Dividend yield
Dividend yield
Average volume
1.36M
Average volume1.36M
High today
$70.15
High today$70.15
Low today
$67.85
Low today$67.85
Open price
$68.18
Open price$68.18
Volume
832.64K
Volume832.64K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$60.11
52 Week low$60.11

Stock Snapshot

With a market cap of 2.38B, TransMedics Group(TMDX) trades at $68.85. The stock has a price-to-earnings ratio of 15.80.

During the trading session on 2026-07-06, TransMedics Group(TMDX) shares reached a daily high of $70.15 and a low of $67.85. At a current price of $68.85, the stock is +1.5% higher than the low and still -1.9% under the high.

Trading activity shows a volume of 832.64K, compared to an average daily volume of 1.36M.

Over the past 52 weeks, TransMedics Group(TMDX) stock has traded between a high of $156.00 and a low of $60.11.

Over the past 52 weeks, TransMedics Group(TMDX) stock has traded between a high of $156.00 and a low of $60.11.

TMDX News

Simply Wall St 1d
Did Rising Transplant Volumes And OCS Expansion Just Shift TransMedics Group's Investment Narrative? - simplywall.st

...

Did Rising Transplant Volumes And OCS Expansion Just Shift TransMedics Group's Investment Narrative? - simplywall.st
Nasdaq 3d
Where Will TransMedics Group Stock Be in 10 Years?

Key Points TransMedics is building more than a medical device business. Its Organ Care System and nationwide transplant logistics network create a difficult-to...

Where Will TransMedics Group Stock Be in 10 Years?
Simply Wall St 3d
TransMedics Stock Looks Undervalued On Earnings While Risks Cloud Fair Value

TransMedics Group stock has more than doubled over the past five years, yet shares are currently well below recent highs. The broader valuation checks still sug...

TransMedics Stock Looks Undervalued On Earnings While Risks Cloud Fair Value

Analyst ratings

73%

of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

More TMDX News

TipRanks 6d
Analyst Maintains Buy on TransMedics, Keeps Price Target Unchanged at $124 Despite Higher Interest Costs and Dilution

TransMedics Group, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William Plovanic from Canaccord Genuity maintained a...

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.